Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer
by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t
Updated on: April 07,2024
19
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer
by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t
Updated on:April 07,2024
19
